- Home
- FF vs OCGN Comparison
FF vs OCGN Comparison
Compare FF & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FF
- OCGN
- Stock Information
- Founded
- FF N/A
- OCGN 2013
- Country
- FF United States
- OCGN United States
- Employees
- FF N/A
- OCGN N/A
- Industry
- FF Major Chemicals
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FF Industrials
- OCGN Health Care
- Exchange
- FF Nasdaq
- OCGN Nasdaq
- Market Cap
- FF 224.1M
- OCGN 252.4M
- IPO Year
- FF N/A
- OCGN N/A
- Fundamental
- Price
- FF $5.18
- OCGN $0.91
- Analyst Decision
- FF Strong Buy
- OCGN Strong Buy
- Analyst Count
- FF 1
- OCGN 3
- Target Price
- FF $0.80
- OCGN $5.67
- AVG Volume (30 Days)
- FF 365.6K
- OCGN 4.3M
- Earning Date
- FF 11-08-2024
- OCGN 11-08-2024
- Dividend Yield
- FF 4.63%
- OCGN N/A
- EPS Growth
- FF 24.25
- OCGN N/A
- EPS
- FF 0.82
- OCGN N/A
- Revenue
- FF $273,839,000.00
- OCGN $4,700,000.00
- Revenue This Year
- FF N/A
- OCGN N/A
- Revenue Next Year
- FF N/A
- OCGN N/A
- P/E Ratio
- FF $6.32
- OCGN N/A
- Revenue Growth
- FF N/A
- OCGN N/A
- 52 Week Low
- FF $4.15
- OCGN $0.36
- 52 Week High
- FF $8.36
- OCGN $2.11
- Technical
- Relative Strength Index (RSI)
- FF 35.96
- OCGN 44.59
- Support Level
- FF $5.07
- OCGN $0.85
- Resistance Level
- FF $5.28
- OCGN $0.94
- Average True Range (ATR)
- FF 0.23
- OCGN 0.08
- MACD
- FF -0.05
- OCGN -0.01
- Stochastic Oscillator
- FF 37.43
- OCGN 19.64
About FF FutureFuel Corp. Common shares
FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").